RO
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Romania
Medical Only (Private)
Reimbursed Care Access
Romania permits limited, regulated medical use of certain dissociative agents (notably esketamine/Spravato and ketamine as an anaesthetic or off‑label psychiatric agent) within the formal healthcare system, while classical serotonergic psychedelics and many entheogens remain scheduled and unavailable outside of approved clinical research. Most tryptamines, phenethylamines (including 2C compounds, MDMA, mescaline) and ibogaine are controlled under national drug‑control law (Law No. 143/2000 and subsequent amendments) and have no authorized medical reimbursement pathways outside approved products or trials.
No clinical trials found for this country yet.